PTC
BIVV

Philadelphia Trust Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Philadelphia Trust Company’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,331
Closed -$611K – 230
2017
Q4 		$611K Buy
11,331
+1,456
+15% +$79.7K 0.05% 144
2017
Q3 		$564K Buy
9,875
+2,975
+43% +$174K 0.05% 146
2017
Q2 		$415K Sell
6,900
-47,408
-87% -$2.7M 0.04% 163
2017
Q1 		$2.96M Buy
+54,308
New +$2.68M 0.24% 82

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Philadelphia Trust Company's BIVV Position: Q1 2018 in Review

Philadelphia Trust Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 11,331 shares — an estimated $611K sold.

Philadelphia Trust Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.96M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Philadelphia Trust Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Philadelphia Trust Company sold 11,331 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $611K.
  • Philadelphia Trust Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Philadelphia Trust Company's Bioverativ Inc. Common Stock position peaked at $2.96M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Philadelphia Trust Company's 13F filing for Q1 2018, filed 14 May 2018.